Aligos Therapeutics (NASDAQ:ALGS) Earns “Buy” Rating from HC Wainwright
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $70.00 target price on the stock. Aligos Therapeutics Stock Performance Shares of ALGS opened at $7.14 on Monday. The stock has a 50 day […]
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $70.00 target price on the stock. Aligos Therapeutics Stock Performance Shares of ALGS opened at $7.14 on Monday. The stock has a 50 day […]
